FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to pharmaceutical compositions for treating or preventing C. difficile infection in an individual. The composition is presented in the form of a solid dosage form and contains a therapeutically effective amount in tiacumicine, a stabilising amount of one or more antioxidants, such as butylated hydroxytoluene, and optionally one or more pharmaceutically acceptable excipients. The invention also refers to a method of treating C. difficile associated diarrhea using the given composition.
EFFECT: compositions of the invention have a high stability and a long shelf life.
14 cl, 5 dwg, 4 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MACROCYCLIC POLYMORPHS, COMPOSITIONS CONTAINING SUCH POLYMORPHS, AND METHODS FOR USING AND PREPARING THEM | 2008 |
|
RU2478643C2 |
| ENCAPSULATED DOSAGE FORM, CONTAINING MONTELUKAST AND LEVOCETIRIZINE | 2012 |
|
RU2606857C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING ALEGLITEZAR | 2010 |
|
RU2537224C2 |
| PHARMACEUTICAL COMPOSITIONS COMPRISING INHIBITOR OF HMG-REDUCTASE | 2000 |
|
RU2206324C1 |
| PHARMACEUTICAL PREPARATIONS WITH FIXED COMBINATION OF ANALGESIC AND ANTISPASMODIC AGENTS DOSES | 2015 |
|
RU2704613C2 |
| STABLE ORAL PHARMACEUTICAL COMPOSITION CONTAINING THYROID HORMONE RECEPTOR AGONISTS | 2007 |
|
RU2450810C2 |
| METHODS AND MEDICINAL FORMULATIONS FOR CONTROLLED DELIVERY OF PALIPERIDONE | 2003 |
|
RU2321391C2 |
| NEW PHARMACEUTICAL COMPOSITION OF TAMSULOZIN AND DUTASTERIDE | 2019 |
|
RU2795928C2 |
| ANTIDIABETIC PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS PREPARING | 1999 |
|
RU2233659C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING THIAGABIN HYDROCHLORIDE | 1996 |
|
RU2173996C2 |
